000 | 01948 a2200553 4500 | ||
---|---|---|---|
005 | 20250514004513.0 | ||
264 | 0 | _c20010913 | |
008 | 200109s 0 0 eng d | ||
022 | _a0006-291X | ||
024 | 7 |
_a10.1006/bbrc.2001.5312 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMorawietz, H | |
245 | 0 | 0 |
_aUpregulation of vascular NAD(P)H oxidase subunit gp91phox and impairment of the nitric oxide signal transduction pathway in hypertension. _h[electronic resource] |
260 |
_bBiochemical and biophysical research communications _cAug 2001 |
||
300 |
_a1130-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAorta, Thoracic _xmetabolism |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aGuanylate Cyclase _xmetabolism |
650 | 0 | 4 |
_aHypertension _xmetabolism |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aLung _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMembrane Glycoproteins _xgenetics |
650 | 0 | 4 |
_aNADH, NADPH Oxidoreductases _xmetabolism |
650 | 0 | 4 | _aNADPH Oxidase 2 |
650 | 0 | 4 | _aNADPH Oxidases |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Donors _xpharmacology |
650 | 0 | 4 | _aProtein Subunits |
650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred SHR |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aSignal Transduction _xphysiology |
650 | 0 | 4 |
_aSuperoxides _xmetabolism |
650 | 0 | 4 | _aUp-Regulation |
650 | 0 | 4 |
_aVasodilation _xdrug effects |
650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
700 | 1 | _aWeber, M | |
700 | 1 | _aRueckschloss, U | |
700 | 1 | _aLauer, N | |
700 | 1 | _aHacker, A | |
700 | 1 | _aKojda, G | |
773 | 0 |
_tBiochemical and biophysical research communications _gvol. 285 _gno. 5 _gp. 1130-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1006/bbrc.2001.5312 _zAvailable from publisher's website |
999 |
_c11405971 _d11405971 |